Shijiazhuang Yiling Pharmaceutical Co., Ltd. (SHE:002603)
China · Delayed Price · Currency is CNY 16.17
-0.18 (-1.10%)
May 20, 2026, 11:34 AM CST
SHE:002603 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Net Income | 1,369 | 1,286 | -724.52 | 1,352 | 2,363 | 1,344 |
Depreciation & Amortization | 625.68 | 625.68 | 611.55 | 548.52 | 451.47 | 362.93 |
Other Amortization | 4.88 | 4.88 | 2.5 | 0.95 | 0.66 | 4.85 |
Loss (Gain) From Sale of Assets | 0.89 | 0.89 | 0.49 | 0.82 | 3.11 | 2.52 |
Asset Writedown & Restructuring Costs | 72.22 | 72.22 | 7 | 11.15 | 95.62 | 10.76 |
Loss (Gain) From Sale of Investments | -7.99 | -7.99 | -44.87 | -78.08 | -11.5 | -4.42 |
Provision & Write-off of Bad Debts | 9.67 | 9.67 | 10.54 | 22.21 | 16.62 | 36.93 |
Other Operating Activities | 263.38 | 75.67 | 259.64 | 58.6 | 44.94 | 51.24 |
Change in Accounts Receivable | -169.2 | -169.2 | 638.25 | -700.49 | -831.66 | -1,280 |
Change in Inventory | 170.93 | 170.93 | 470.32 | -459.67 | -348.01 | -104.74 |
Change in Accounts Payable | -416.87 | -416.87 | -447.3 | -722.76 | 1,886 | 55.15 |
Change in Other Net Operating Assets | -18.18 | -18.18 | 25.55 | 17.35 | -22.82 | 29.75 |
Operating Cash Flow | 2,047 | 1,777 | 611.01 | 155.46 | 3,488 | 528.69 |
Operating Cash Flow Growth | 145.43% | 190.75% | 293.04% | -95.54% | 559.69% | -66.67% |
Capital Expenditures | -261.09 | -245.62 | -290.39 | -310.83 | -213.98 | -673.56 |
Sale of Property, Plant & Equipment | 0.06 | 0.06 | 0.02 | 0.97 | 0.35 | 1.2 |
Cash Acquisitions | - | - | - | -676.29 | - | - |
Investment in Securities | -1,481 | -760.5 | 1,785 | 49.1 | -1,789 | 159.33 |
Other Investing Activities | 8.63 | 4.08 | 117.4 | 37.83 | 7.66 | 6.28 |
Investing Cash Flow | -1,733 | -1,002 | 1,612 | -899.22 | -1,995 | -506.76 |
Short-Term Debt Issued | - | - | 282 | 500 | - | - |
Long-Term Debt Issued | - | - | 870 | 1,200 | 1,850 | 2,400 |
Total Debt Issued | - | - | 1,152 | 1,700 | 1,850 | 2,400 |
Short-Term Debt Repaid | - | - | -782 | -393 | - | - |
Long-Term Debt Repaid | - | -12.31 | -2,277 | -654.82 | -2,204 | -1,483 |
Total Debt Repaid | -12.31 | -12.31 | -3,059 | -1,048 | -2,204 | -1,483 |
Net Debt Issued (Repaid) | -12.31 | -12.31 | -1,907 | 652.18 | -354.3 | 916.81 |
Issuance of Common Stock | - | - | 30.5 | - | - | - |
Common Dividends Paid | -501.21 | -501.21 | -375.31 | -872.77 | -282.7 | -1,220 |
Other Financing Activities | -2.14 | -0.11 | -1.32 | - | - | 1.18 |
Financing Cash Flow | -515.66 | -513.63 | -2,253 | -220.59 | -637 | -302.15 |
Foreign Exchange Rate Adjustments | -0.62 | -0.81 | 0.11 | 0.33 | 1.25 | -0.48 |
Net Cash Flow | -202.26 | 260.09 | -30.03 | -964.03 | 857.18 | -280.69 |
Free Cash Flow | 1,786 | 1,531 | 320.62 | -155.38 | 3,274 | -144.87 |
Free Cash Flow Growth | 214.53% | 377.48% | - | - | - | - |
Free Cash Flow Margin | 22.57% | 19.55% | 4.92% | -1.51% | 26.12% | -1.43% |
Free Cash Flow Per Share | 1.07 | 0.92 | 0.19 | -0.09 | 1.96 | -0.09 |
Cash Income Tax Paid | 1,007 | 898.98 | 711.26 | 1,324 | 1,322 | 1,174 |
Levered Free Cash Flow | 1,337 | 1,133 | 656.46 | 102.54 | 3,670 | 251.91 |
Unlevered Free Cash Flow | 1,338 | 1,133 | 674.59 | 126.86 | 3,691 | 273.14 |
Change in Working Capital | -290.98 | -290.98 | 488.67 | -1,761 | 524.07 | -1,280 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.